(Q40634455)

English

Loss of activator protein-2alpha results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma

scientific article published on 15 September 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 September 2017

Loss of activator protein-2alpha results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma (English)

1 reference

Europe PubMed Central

22 September 2017

1 reference

based on heuristic

inferred from title

author name string

Carmen Tellez

1

1 reference

Europe PubMed Central

22 September 2017

Marya McCarty

2

1 reference

Europe PubMed Central

22 September 2017

Maribelis Ruiz

3

1 reference

Europe PubMed Central

22 September 2017

Menashe Bar-Eli

4

1 reference

Europe PubMed Central

22 September 2017

language of work or name

0 references

publication date

15 September 2003

1 reference

Europe PubMed Central

22 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

22 September 2017

278

1 reference

Europe PubMed Central

22 September 2017

46632-46642

1 reference

Europe PubMed Central

22 September 2017

47

1 reference

Europe PubMed Central

22 September 2017

Role of AP-2 in tumor growth and metastasis of human melanoma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Melanoma progression-associated glycoprotein MUC18/MCAM mediates homotypic cell adhesion through interaction with a heterophilic ligand

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Activation of transcription factor AP-2 mediates UVA radiation- and singlet oxygen-induced expression of the human intercellular adhesion molecule 1 gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Transcription factor AP-2 controls transcription of the human transforming growth factor-alpha gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Ultraviolet-A-induced transactivation of the vascular endothelial growth factor gene in HaCaT keratinocytes is conveyed by activator protein-2 transcription factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

The repressive function of AP2 transcription factor on the hepatocyte growth factor gene promoter

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Cellular consequences of thrombin-receptor activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Thrombin receptor activation results in calcium signaling and protein kinase C-dependent stimulation of DNA synthesis in HEp-2g laryngeal carcinoma cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Role of thrombin receptor in breast cancer invasiveness

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Expression of protease-activated receptor 1 in oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Thrombin receptor overexpression in malignant and physiological invasion processes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha vbeta 5 integrin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Cloning and identification of regulatory sequences of the human thrombin receptor gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Differential transcriptional regulation of the human thrombin receptor gene by the Sp family of transcription factors in human endothelial cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha -induced block of p65/p50 nuclear translocation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Promoter elements of the mouse acetylcholinesterase gene. Transcriptional regulation during muscle differentiation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Regulation of K3 keratin gene transcription by Sp1 and AP-2 in differentiating rabbit corneal epithelial cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Dual regulation of ets-activated gene expression by SP1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Modulation of the folate receptor type beta gene by coordinate actions of retinoic acid receptors at activator Sp1/ets and repressor AP-1 sites

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Combinatorial action of HNF3 and Sp family transcription factors in the activation of the rabbit uteroglobin/CC10 promoter

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Stat1 depends on transcriptional synergy with Sp1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

The transcription factors Sp1 and Oct-1 interact physically to regulate human U2 snRNA gene expression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Functional synergy and physical interactions of the erythroid transcription factor GATA-1 with the Krüppel family proteins Sp1 and EKLF.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Gene regulation in melanoma progression by the AP-2 transcription factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Expression of AP-2 transcription factor and of its downstream target genes c-kit, E-cadherin and p21 in human cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309159200

21 January 2018

Identifiers

10.1074/JBC.M309159200

1 reference

Europe PubMed Central

22 September 2017

1 reference

Europe PubMed Central

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40634455&oldid=1903822895"